Physician profile
Vulihn Ta
NPI 1114965308
$1,553.21
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $41.37 · 2021: $310 · 2022: $394 · 2023: $293 · 2024: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $556.93 | 2020-2023 | Omni Hysteroscope, Acessa Provu System |
| Intuitive Surgical, INC. | $310.16 | 2019-2022 | |
| Abbvie INC. | $210.11 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Organon LLC | $208.04 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $124.52 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.64 | 2019-2024 | |
| Minerva Surgical, INC | $36.19 | 2019 | |
| Coopersurgical, INC. | $31.62 | 2023 | Vaginal Speculum - Snowman/ Pederson Blade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vulihn Ta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.